# EDGAR Filing Document

**Accession Number:** 0000882291
**File Stem:** 0001683168-25-006557
**Filing Date:** 2025-8
**Character Count:** 2648
**Document Hash:** 0a26ba596cc752e57c3362c5931917ef
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-006557.hdr.sgml**: 20251120

**ACCESSION NUMBER**: 0001683168-25-006557

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AETHLON MEDICAL INC
- **CENTRAL INDEX KEY:** 0000882291
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 133632859
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 11555 SORRENTO VALLEY ROAD, SUITE 203
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** 619-941-0360

**MAIL ADDRESS:**
- **STREET 1:** 11555 SORRENTO VALLEY ROAD, SUITE 203
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BISHOP EQUITIES INC
- **DATE OF NAME CHANGE:** 19930602

**MAXIM GROUP LLC**

**300 Park Avenue, 16<sup>th</sup> Floor<br> New York, New York 10022**

August 29, 2025

**VIA EDGAR CORRESPONDENCE**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.<br> Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Aethlon Medical, Inc.<br> Registration Statement on Form S-1, as amended** |
|  | **File No. 333-289745** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), we, the underwriter, hereby request that the Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced registration statement on Form S-1 (the "Registration Statement") to become effective at 5:01 p.m., Eastern time, on Tuesday, September 2, 2025, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated August 29, 2025 to agents, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned, as underwriter, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. If you require any additional information with respect to this letter, please contact M. Ali Panjwani at (212) 326-0820 of Pryor Cashman LLP.

Very truly yours,<br>MAXIM GROUP LLC<br>By: <u>/s/ Ritesh M. Veera</u> <br> Ritesh M. Veera<br> Co-Head of Investment Banking<br>

cc: M. Ali Panjwani, Esq. <br> Pryor Cashman LLP